Human & Animal Primary Cells
Primary cells are directly isolated from human or animal tissues and closely mimic the physiological state of cells in vivo. Unlike immortalized cell lines, primary cells have a limited lifespan, maintaining their original phenotypic and functional characteristics. They are a critical resource for studying biological mechanisms, drug screening, and translational research due to their relevance to natural cellular processes.
Content on Human & Animal Primary Cells
Characteristics:
- Source: Derived from specific tissues, including blood, skin, lung, liver, and brain.
- Heterogeneity: Retain the diversity of cell types present in the original tissue.
- Limited Proliferation: Exhibit finite division potential governed by the Hayflick limit.
- Specificity: Maintain organ- and species-specific markers and functions.
Cultivation:
- Require specialized growth media enriched with tissue-specific growth factors.
- Strict sterility and adherence to optimal environmental conditions are essential for viability.
- Contamination risks, particularly from mycoplasma, require routine monitoring.
Applications of Human & Animal Primary Cells
- Biomedical Research:
- Used to study physiological and pathological processes at the cellular level.
- Enable the investigation of species-specific responses.
- Drug Discovery & Development:
- Predictive toxicology and pharmacokinetic studies in primary hepatocytes.
- High-fidelity models for efficacy testing.
- Cancer Research:
- Tumor-derived primary cells aid in understanding patient-specific cancer behavior.
- Essential for precision medicine and therapeutic targeting.
Primary cells provide unparalleled physiological relevance, making them indispensable tools for studies requiring accurate biological modeling. Their use underscores the necessity for high-quality isolation and culture techniques to maximize experimental fidelity.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|